148 related articles for article (PubMed ID: 30839064)
1. Cost-Efficiency of Breast Cancer Care in the US Military Health System: An Economic Evaluation in Direct and Purchased Care.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Oct; 184(9-10):e494-e501. PubMed ID: 30839064
[TBL] [Abstract][Full Text] [Related]
2. Costs for Colon Cancer Treatment Comparing Benefit Types and Care Sources in the US Military Health System.
Eaglehouse YL; Georg MW; Richard P; Shriver CD; Zhu K
Mil Med; 2019 Dec; 184(11-12):e847-e855. PubMed ID: 30941433
[TBL] [Abstract][Full Text] [Related]
3. Costs for Breast Cancer Care in the Military Health System: An Analysis by Benefit Type and Care Source.
Eaglehouse YL; Manjelievskaia J; Shao S; Brown D; Hofmann K; Richard P; Shriver CD; Zhu K
Mil Med; 2018 Nov; 183(11-12):e500-e508. PubMed ID: 29660010
[TBL] [Abstract][Full Text] [Related]
4. Contribution Of Care Source To Cancer Treatment Cost Variation In The US Military Health System.
Eaglehouse YL; Aljehani M; Georg MW; Castellanos O; Lee JSH; Seabury SA; Shriver CD; Zhu K
Health Aff (Millwood); 2019 Aug; 38(8):1335-1342. PubMed ID: 31381409
[TBL] [Abstract][Full Text] [Related]
5. The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source.
Eaglehouse YL; Shao S; Chan W; Brown D; Manjelievskaia J; Shriver CD; Zhu K
J Cancer Surviv; 2018 Jun; 12(3):407-416. PubMed ID: 29455447
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Treatment and Survival Among Department of Defense Beneficiaries: An Analysis by Benefit Type and Care Source.
Manjelievskaia J; Brown D; Shao S; Hofmann K; Shriver CD; Zhu K
Mil Med; 2018 Mar; 183(3-4):e186-e195. PubMed ID: 29365174
[TBL] [Abstract][Full Text] [Related]
7. Purchased Behavioral Health Care Received by Military Health System Beneficiaries in Civilian Medical Facilities, 2000-2014.
Wooten NR; Brittingham JA; Pitner RO; Tavakoli AS; Jeffery DD; Haddock KS
Mil Med; 2018 Jul; 183(7-8):e278-e290. PubMed ID: 29420772
[TBL] [Abstract][Full Text] [Related]
8. In defense of Direct Care: Limiting access to military hospitals could worsen quality and safety.
Zogg CK; Lichtman JH; Dalton MK; Learn PA; Schoenfeld AJ; Perez Koehlmoos T; Weissman JS; Cooper Z
Health Serv Res; 2022 Aug; 57(4):723-733. PubMed ID: 34608642
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy Treatment Costs and Clinical Outcomes of Colon Cancer in the U.S. Military Health System's Direct and Private Sector Care Settings.
Eaglehouse YL; Seabury SA; Aljehani M; Koehlmoos T; Lee JSH; Shriver CD; Zhu K
Mil Med; 2023 Nov; 188(11-12):e3439-e3446. PubMed ID: 37167011
[TBL] [Abstract][Full Text] [Related]
10. Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
Ansaripour A; Zendehdel K; Tadayon N; Sadeghi F; Uyl-de Groot CA; Redekop WK
PLoS One; 2018; 13(10):e0205079. PubMed ID: 30273393
[TBL] [Abstract][Full Text] [Related]
11. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
[TBL] [Abstract][Full Text] [Related]
12. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Epstein AJ; Wong YN; Mitra N; Vachani A; Hin S; Yang L; Smith-McLallen A; Armstrong K; Groeneveld PW
J Clin Oncol; 2015 Dec; 33(36):4259-67. PubMed ID: 26598749
[TBL] [Abstract][Full Text] [Related]
14. Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis Among DoD Beneficiaries.
Manjelievskaia J; Brown D; Shao S; Hofmann K; Shriver CD; Zhu K
Mil Med; 2017 Mar; 182(3):e1782-e1789. PubMed ID: 28290959
[TBL] [Abstract][Full Text] [Related]
15. Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer.
Ritz LJ; Nissen MJ; Swenson KK; Farrell JB; Sperduto PW; Sladek ML; Lally RM; Schroeder LM
Oncol Nurs Forum; 2000 Jul; 27(6):923-32. PubMed ID: 10920832
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study.
Castro F; Shahal D; Tarajia M; Velásquez IM; Causadias MT; Herrera V; Gómez B; Cukier M; Motta J
BMJ Open; 2017 Sep; 7(9):e017266. PubMed ID: 28947456
[TBL] [Abstract][Full Text] [Related]
17. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
18. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
19. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
